Tocilizumab: blockade of interleukin-6 signaling pathway as a therapeutic strategy for inflammatory disorders (Q36617843)

From Wikidata
Jump to navigation Jump to search
scientific article published on September 2006
edit
Language Label Description Also known as
English
Tocilizumab: blockade of interleukin-6 signaling pathway as a therapeutic strategy for inflammatory disorders
scientific article published on September 2006

    Statements

    Tocilizumab: blockade of interleukin-6 signaling pathway as a therapeutic strategy for inflammatory disorders (English)
    Kalanethee Paul-Pletzer
    1 September 2006
    559-576

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit